HIF-1α (Hypoxia-Inducible Factor 1-Alpha)

HIF-1α (Hypoxia-Inducible Factor 1-Alpha)

Overview

HIF-1α (Hypoxia-Inducible Factor 1-alpha) is the oxygen-sensitive subunit of the HIF-1 transcription factor heterodimer. It is the master regulator of cellular adaptation to low oxygen tension (hypoxia), controlling the expression of hundreds of genes involved in energy metabolism, angiogenesis, erythropoiesis, and cell survival [@semenza2012]. HIF-1α dimerizes with HIF-1β (ARNT) to form the active transcription factor, which binds to hypoxia-response elements (HREs) in the promoters of target genes. Under normoxic conditions, HIF-1α is continuously degraded via the VHL-dependent ubiquitin-proteasome pathway. Under hypoxia, degradation is inhibited, allowing HIF-1α to accumulate, translocate to the nucleus, and activate its transcriptional program [@wang1995].

HIF-1α (Hypoxia-Inducible Factor 1-Alpha)

Overview

HIF-1α (Hypoxia-Inducible Factor 1-alpha) is the oxygen-sensitive subunit of the HIF-1 transcription factor heterodimer. It is the master regulator of cellular adaptation to low oxygen tension (hypoxia), controlling the expression of hundreds of genes involved in energy metabolism, angiogenesis, erythropoiesis, and cell survival [@semenza2012]. HIF-1α dimerizes with HIF-1β (ARNT) to form the active transcription factor, which binds to hypoxia-response elements (HREs) in the promoters of target genes. Under normoxic conditions, HIF-1α is continuously degraded via the VHL-dependent ubiquitin-proteasome pathway. Under hypoxia, degradation is inhibited, allowing HIF-1α to accumulate, translocate to the nucleus, and activate its transcriptional program [@wang1995].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2">HIF-1α Protein</th></tr>
<tr><td>Protein Name</td><td>Hypoxia-Inducible Factor 1-Alpha</td></tr>
<tr><td>Gene</td><td>[HIF1A](/genes/hif1a)</td></tr>
<tr><td>UniProt ID</td><td>[Q16665](https://www.uniprot.org/uniprot/Q16665)</td></tr>
<tr><td>PDB IDs</td><td>1H2M, 4H6J</td></tr>
<tr><td>Molecular Weight</td><td>92.6 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Nucleus, Cytoplasm</td></tr>
<tr><td>Protein Family</td><td>bHLH-PAS transcription factor family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">586 edges</a></td>
</tr>
</table>
</div>

Structure

HIF-1α is a 826-amino acid protein with distinct structural domains:

Heterodimerization with HIF-1β (ARNT) occurs via the PAS domains, creating a functional transcription factor complex that recruits the coactivator p300/CBP via the TAD domains.

Regulation

Oxygen-Dependent Regulation

The canonical regulation of HIF-1α is oxygen-dependent:

Additional Regulatory Mechanisms

• Asparagine hydroxylation: Factor inhibiting HIF (FIH) hydroxylates Asn803 in the C-TAD under moderate hypoxia, blocking p300 recruitment
• Post-translational modifications: Phosphorylation (by GSK3β, MAPK), acetylation (by p300), and SUMOylation modulate stability and activity
• Transcriptional and translational control: HIF1A mRNA can be translationally upregulated under stress conditions
• Feedback regulation: HIF-1 induces PHD2 and PHD3 expression, creating a negative feedback loop that tunes the hypoxic response

Normal Function

HIF-1α is the central mediator of the cellular adaptive response to hypoxia:

Metabolic Adaptation

• Glycolysis upregulation: Induces GLUT1 (SLC2A1), hexokinases (HK1, HK2), phosphofructokinase (PFKL), and pyruvate dehydrogenase kinase 1 (PDK1), shifting energy production from oxidative phosphorylation to glycolysis
• Angiogenesis: Induces VEGF (VEGFA) and VEGFR2 expression to promote new blood vessel formation
• Erythropoiesis: Induces EPO (erythropoietin) to stimulate red blood cell production
• Autophagy: Activates BNIP3 and other autophagy genes to promote cell survival under stress

Cell Survival Pathways

• Anti-apoptotic genes: Induces BCL2, survivin (BIRC5), and erythropoietin for direct neuroprotective effects
• DNA repair genes: Upregulates genes involved in base excision repair and homologous recombination
• Stress response genes: Activates HO-1 (heme oxygenase 1) and other antioxidant response genes

Tissue-Specific Functions

• Brain: Regulates cerebral blood flow, metabolic adaptation to ischemia, and neuroprotection
• Retina: Critical for retinal vascularization and photoreceptor survival
• Kidney: Central regulator of erythropoietin production
• Heart: Cardioprotection during ischemic episodes

Role in Neurodegeneration

The role of HIF-1α in neurodegenerative diseases is complex and context-dependent, with both neuroprotective and detrimental effects documented [@cheng2021].

Alzheimer's Disease

In AD, HIF-1α plays a dual role:

Neuroprotective effects:

• HIF-1α activation is a compensatory response to chronic cerebral hypoperfusion observed in AD [@correia2021]
• VEGF induction promotes angiogenesis and may improve cerebral blood flow
• Glycolytic shift helps neurons maintain ATP production despite mitochondrial dysfunction
• Induction of amyloid-degrading enzymes (IDE, MMP9) may reduce Aβ burden
• EPO and other HIF target genes provide direct neuroprotection

• Chronic HIF-1α activation may promote Aβ production via increased APP expression
• Can contribute to neuroinflammation through VEGF-mediated blood-brain barrier disruption
• May promote tau hyperphosphorylation through metabolic stress pathways

Parkinson's Disease

In PD, HIF-1α provides neuroprotection to dopaminergic neurons [@wang2020]:

• Ischemic preconditioning: Prior exposure to mild hypoxia via HIF-1α activation protects neurons against subsequent severe insults
• Mitochondrial protection: HIF-1α helps neurons cope with mitochondrial Complex I deficiency common in PD
• α-synuclein toxicity: HIF-1α activation can reduce α-synuclein aggregation and protect against dopaminergic neuronal death
• Inflammatory modulation: Regulates microglial activation and neuroinflammatory responses

Stroke and Ischemia

HIF-1α is acutely protective in cerebral ischemia:

• Ischemic preconditioning (IPC) induces HIF-1α and protects against subsequent stroke [@sharp2004]
• HIF-1α target genes (EPO, VEGF, GLUT1, BDNF) promote neuronal survival and tissue perfusion
• Pharmacologic HIF activation before stroke is neuroprotective in animal models
• However, timing is critical — excessive late-phase HIF activation may worsen outcomes

ALS and Motor Neuron Disease

• HIF-1α dysregulation is observed in SOD1 mouse models and human ALS tissue
• Motor neurons are particularly vulnerable to hypoxic stress
• Therapeutic targeting of HIF pathways is under investigation

Multiple Sclerosis

HIF-1α plays context-dependent roles in MS:

• Myelin repair: HIF-1α promotes oligodendrocyte precursor differentiation
• Blood-brain barrier: HIF-1α regulates BBB integrity
• Autoimmunity: T cell HIF-1α affects cytokine production

Vascular Cognitive Impairment

Cerebral small vessel disease shares features with AD:

• Chronic hypoperfusion: Reduced cerebral blood flow in VCID
• White matter lesions: HIF-1α in demyelinating lesions
• Therapeutic potential: HIF stabilization may improve outcomes

Traumatic Brain Injury

HIF-1α responds to acute brain injury:

• Acute neuroprotection: Early HIF-1α activation is protective
• Angiogenesis: Promotes revascularization
• Long-term outcomes: Complex, timing-dependent effects

COVID-19 and the Brain

Emerging evidence links COVID-19 to neurological symptoms:

• Hypoxia: Severe COVID-19 causes cerebral hypoxia
• Cognitive impairment: "Long COVID" includes brain fog
• HIF-1α: May mediate both protective and pathological responses

Molecular Mechanisms

HIF Target Gene Network

HIF-1α regulates hundreds of genes through hypoxia response elements (HREs, 5'-RCGTG-3'):

Metabolic Genes

| Gene | Function | Relevance to Neurodegeneration |
|------|----------|------------------------------|
| GLUT1 (SLC2A1) | Glucose transporter | Metabolic adaptation |
| HK1/HK2 | Hexokinases | Glycolysis |
| PDK1 | Pyruvate dehydrogenase kinase | Metabolic shift |
| LDHA | Lactate dehydrogenase | Glycolysis |

Angiogenesis Genes

| Gene | Function | Relevance to Neurodegeneration |
|------|----------|------------------------------|
| VEGFA | Vascular endothelial growth factor | Angiogenesis, also neurotoxic in excess |
| ANGPTL4 | Angiopoietin-like 4 | Permeability |
| PLIN2 | Perilipin 2 | Lipid metabolism |

Survival Genes

| Gene | Function | Relevance to Neurodegeneration |
|------|----------|------------------------------|
| EPO | Erythropoietin | Neuroprotection |
| BCL2 | Anti-apoptotic | Cell survival |
|survivin (BIRC5) | Inhibitor of apoptosis | Cell division |
| NQO1 | NADPH quinone dehydrogenase | Antioxidant |

Autophagy Genes

| Gene | Function | Relevance to Neurodegeneration |
|------|----------|------------------------------|
| BNIP3 | Pro-autophagic | Mitophagy |
| BNIP3L/NIX | Pro-autophagic | Mitophagy |
| MAP1LC3B | Microtubule-associated | Autophagosome |
| p62/SQSTM1 | Selective autophagy | Protein clearance |

Non-Hypoxic HIF Activation

HIF-1α can be activated without hypoxia:

Growth Factor Signaling

• PI3K/AKT/mTOR pathway: AKT promotes HIF-1α translation
• MAPK pathway: ERK1/2 enhances HIF-1α transcriptional activity
• GSK3β: Paradoxically promotes degradation

Inflammatory Signaling

• NF-κB: Cross-talk with HIF-1α transcription
• TNF-α: Can stabilize HIF-1α
• IL-1β: Synergistic activation

Metabolic Signaling

• Succinate accumulation: Inhibits PHD, stabilizes HIF
• Fumarate: Fumarate accumulation (FH mutations) stabilizes HIF
• Reactive oxygen species: Can promote HIF activation

HIF Isoforms and Specificity

HIF-1α vs. HIF-2α (EPAS1)

| Feature | HIF-1α | HIF-2α (EPAS1) |
|---------|--------|----------------|
| Gene | HIF1A | EPAS1 |
| Expression | Ubiquitous | Endothelial cells, brain |
| Target genes | Overlapping but distinct | Some unique targets |
| Role in cancer | Promotes proliferation | Promotes tumor growth |
| Neuronal role | Acute response | Chronic hypoxia |

HIF-1β (ARNT)

• Constitutively expressed
• Shared subunit for HIF-1α and HIF-2α
• Essential for dimerization
• Not oxygen-regulated

Therapeutic Targeting

HIF Prolyl Hydroxylase Inhibitors (HIF-PHI)

These small molecules stabilize HIF-1α by inhibiting PHD enzymes, mimicking the hypoxic response:

| Drug | Target | Status | Notes |
|------|--------|--------|-------|
| Roxadustat (FG-4592) | PHD1/2/3 | Approved (ESA) | FDA-approved for anemia; CNS penetration being studied |
| Vadadustat (AKB-6548) | PHD1/2/3 | Approved (ESA) | Similar profile to roxadustat |
| Daprodustat (GSK1278863) | PHD1/2/3 | Approved (ESA) | Approved for anemia in CKD |
| FG-2216 | PHD | Preclinical | First-generation compound |

Neurodegeneration research:

• Roxadustat and vadadustat show neuroprotective effects in mouse models of stroke, AD, and PD
• Preconditioning effect: PHD inhibitors administered 24-48h before stroke reduce infarct volume
• Clinical trials for neuroprotection are in early stages [@vangeel2020; @masson2019]

Gene Therapy Approaches

• Viral delivery of HIF-1α or PHD shRNA to the brain
• Exosomes loaded with HIF-1α mRNA for targeted delivery
• Cell-permeable peptides stabilizing HIF-1α

Small Molecule Activators

• DMOG (dimethyloxalylglycine): Pan-PHD inhibitor, widely used in research, not clinically available
• CoCl₂: Chemical hypoxia mimetic, induces HIF-1α but toxic at high doses
• Angiotensin II: Indirectly activates HIF-1α via AT1 receptor

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|----------------|----------------------|
| HIF-1β (ARNT) | Heterodimerization | Forms active transcription factor complex |
| VHL | E3 ligase binding | Normoxic degradation via ubiquitin-proteasome |
| PHD1/2/3 (EGLN1/2/3) | Prolyl hydroxylation | Oxygen-dependent regulation |
| FIH (HIF1AN) | Asparaginyl hydroxylation | Blocks p300 recruitment |
| p300/CBP | Coactivator recruitment | Transcriptional activation |
| HDAC1/2/3 | Deacetylase interaction | Modulates transcriptional activity |
| GSK3β | Phosphorylation | Promotes proteasomal degradation |
| PIN1 | Prolyl isomerization | Modulates stability and activity |

Research Directions

Pathway & Interaction Diagram

Interactive diagram showing HIF1A key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• [HIF1A Gene](/genes/hif1a)
• [HIF-1α Pathway](/mechanisms/hif-signaling)
• [Hypoxia and Neurodegeneration](/mechanisms/hypoxia-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neurovascular Unit](/mechanisms/neurovascular-unit)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)

References